Eva Maria Putz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Eva Maria Putz

Showing results (21-30 of 25) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 25 results.

Frontiers in Immunology|July 22, 2024

STAT3 in acute myeloid leukemia facilitates natural killer cell-mediated surveillanceAgnieszka Witalisz-Siepracka, Clio-Melina Denk, Bernhard Zdársky, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 15, 2023

NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophagesDongchen Yuan, Jing Hu, Xiaoman Ju, et al.

Cancer Cell|March 20, 2018

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma MicroenvironmentKyohei Nakamura, Sahar Kassem, Alice Cleynen, et al.

Oncoimmunology|July 3, 2015

Myeloid <i>STAT3</i> promotes formation of colitis-associated colorectal cancer in micePaulina Pathria, Dagmar Gotthardt, Michaela Prchal-Murphy, et al.

Blood|June 17, 2018

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapyEdit Porpaczy, Sabrina Tripolt, Andrea Hoelbl-Kovacic, et al.

Pageof 3

Search research articles

Showing results (21-30 of 25) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 25 results.

Frontiers in Immunology|July 22, 2024

STAT3 in acute myeloid leukemia facilitates natural killer cell-mediated surveillanceAgnieszka Witalisz-Siepracka, Clio-Melina Denk, Bernhard Zdársky, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 15, 2023

NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophagesDongchen Yuan, Jing Hu, Xiaoman Ju, et al.

Cancer Cell|March 20, 2018

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma MicroenvironmentKyohei Nakamura, Sahar Kassem, Alice Cleynen, et al.

Oncoimmunology|July 3, 2015

Myeloid <i>STAT3</i> promotes formation of colitis-associated colorectal cancer in micePaulina Pathria, Dagmar Gotthardt, Michaela Prchal-Murphy, et al.

Blood|June 17, 2018

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapyEdit Porpaczy, Sabrina Tripolt, Andrea Hoelbl-Kovacic, et al.

Pageof 3